Booster Strategies After Janssen Shot Increased Protection Against Omicron
Vaccination with one Janssen dose plus mRNA booster provides higher protection than two Janssen doses.
Vaccination with one Janssen dose plus mRNA booster provides higher protection than two Janssen doses.
During omicron-predominant period, effectiveness of two doses against hospitalization 68 percent for children, 40 percent for adolescents.
Most cancer patients should receive 3 primary doses of an mRNA COVID-19 vaccine and 2 booster doses, according to NCCN.
Large population-based cohort of more than 22,000 women shows no increased risks with vaccination during pregnancy.
Of the NHL patients with neutralizing antibodies against the WA1/2020 SARS-CoV-2 strain, 70% had antibodies against the delta variant, and 33% had antibodies against the omicron variant.
No major adverse events seen among 15 children with MIS-C who were subsequently vaccinated against SARS-CoV-2.
However, breakthrough infections among J&J vaccine recipients were similar or lower compared to the other vaccines.
Echoing the FDA, the CDC also supported a second booster for ‘certain immune-compromised individuals’.
Vaccination within teratogenic window not linked to presence of congenital anomalies identified on ultrasonography.
Vaccine efficacy 30 percent for BNT162b2 and 11 percent for mRNA-1273 against any SARS-CoV-2 infection.